BP & Arzeda: mystery renewable chemical in focus
In Washington state, BP and Arzeda entered a second extended collaboration agreement for developing a bio-process for production of a renewable chemical of high strategic and industrial interest to BP.
After successful completion of the first phase of the project, BP and Arzeda chose to enter the second phase with the aim to accelerate progress towards commercialization of the target chemical by building on the two companies complementary technologies and core competencies. Arzeda reached a major deliverable in the previous engagement, which set the stage for BP to move to this extended agreement.
Arzeda is harnessing the power of computational protein design to build novel enzymes and discover new pathways that enable cost effective, sustainable production of value-added specialty chemicals and ingredients. In partnership with Fortune 500 companies and industrial leaders, the company has developed a portfolio of enzymes that increase the efficiency, robustness and diversity of biological processes. Our proprietary pathway design software unlocks new opportunities for specialty chemicals, advanced materials and health and nutrition products that would otherwise be impossible to exploit.
Arzeda’s protein design technology, Archytas is uniquely positioned, the company noted, to enable improved enzymes that drive the production of new products with attractive performance and economic value.
Reaction from Arzeda
Alexandre Zanghellini, Arzeda’s CEO, commented, “A returning partner is a tremendous validation of our technology and the collective effort of the Arzeda and BP teams. We look forward to continue building value for BP and the next equally fruitful collaboration!”
Category: Fuels
